Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jun;102(6):1151.
doi: 10.4269/ajtmh.20-0239.

COVID-19: The Need for Immunoprevention at Industrial Scale

Scott B Halstead  1
Affiliations
Editorial

COVID-19: The Need for Immunoprevention at Industrial Scale

Scott B Halstead. Am J Trop Med Hyg. 2020 Jun.
No abstract available

PubMed Disclaimer

Similar articles

  • An Urgent Need for "Common Cold Units" to Study COVID-19.
    Halstead SB. Halstead SB. Am J Trop Med Hyg. 2020 Jun;102(6):1152-1153. doi: 10.4269/ajtmh.20-0246. Am J Trop Med Hyg. 2020. PMID: 32274988 Free PMC article. No abstract available.
  • All together to Fight COVID-19.
    Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N. Momtazmanesh S, et al. Am J Trop Med Hyg. 2020 Jun;102(6):1181-1183. doi: 10.4269/ajtmh.20-0281. Am J Trop Med Hyg. 2020. PMID: 32323644 Free PMC article.
  • COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG, Andricopulo AD. Ferreira LLG, et al. Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334. Curr Top Med Chem. 2020. PMID: 32862824 No abstract available.
  • Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N, Li C, Hu Y, Li K, Liang J, Wang L, Du L, Jiang S. Zhang N, et al. Microbes Infect. 2020 Jul-Aug;22(6-7):231-235. doi: 10.1016/j.micinf.2020.05.001. Epub 2020 May 6. Microbes Infect. 2020. PMID: 32387332 Free PMC article. Review.
  • COVID-19: Main therapeutic options.
    Hachfi W, Ben Lasfar N. Hachfi W, et al. Tunis Med. 2020 Apr;98(4):299-303. Tunis Med. 2020. PMID: 32395792 Review. No abstract available.
See all similar articles

References

    1. Prompetchara E, Ketloy C, Palaga T, 2020. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38: 1–9. - PubMed
    1. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H, 2020. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 117: 6771–6776. - PMC - PubMed
    1. Casadevall A, Pirofski LA, 2020. The convalescent sera option for containing COVID-19. J Clin Invest 130: 1545–1548. - PMC - PubMed
    1. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211: 80–90. - PMC - PubMed
    1. Young MK, Nimmo GR, Cripps AW, Jones MA, 2014. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst Rev 1(4): CD010056. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources